Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin

PHASE3CompletedINTERVENTIONAL
Enrollment

368

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

May 31, 2011

Conditions
Hypotrichosis
Interventions
DRUG

Bimatoprost 0.03% solution

Once daily, one drop of Bimatoprost 0.03% solution using a single-use per eye applicator will be applied to the upper eyelid margin (where the eyelashes meet the skin).

DRUG

Vehicle solution

Once daily, one drop of vehicle solution using a single-use per eye applicator will be applied to the upper eyelid margin (where the eyelashes meet the skin).

Trial Locations (2)

Unknown

San Diego

London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT00907426 - Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin | Biotech Hunter | Biotech Hunter